{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:17:39Z","timestamp":1792801059455,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,4,10]],"date-time":"2017-04-10T00:00:00Z","timestamp":1491782400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Genet"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1038\/ng.3836","type":"journal-article","created":{"date-parts":[[2017,4,10]],"date-time":"2017-04-10T15:18:14Z","timestamp":1491837494000},"page":"795-800","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":91,"title":["IFN-\u03bb3, not IFN-\u03bb4, likely mediates IFNL3\u2013IFNL4 haplotype\u2013dependent hepatic inflammation and fibrosis"],"prefix":"10.1038","volume":"49","author":[{"name":"the International Liver Disease Genetics Consortium (ILDGC)","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Eslam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan","family":"McLeod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kebitsaone Simon","family":"Kelaeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Mangia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Thabet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William L","family":"Irving","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J","family":"Dore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sheridan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Gr\u00f8nb\u00e6k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Lorena","family":"Abate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1159-066X","authenticated-orcid":false,"given":"Rune","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Bugianesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Spengler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R","family":"Booth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Weltman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Mollison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Riordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hema","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janett","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Nattermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4621-3485","authenticated-orcid":false,"given":"Mark W","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Liddle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Romero-Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,10]]},"reference":[{"key":"BFng3836_CR1","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/hep.24678","volume":"55","author":"PY Bochud","year":"2012","unstructured":"Bochud, P.Y. et al. IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes. Hepatology 55, 384\u2013394 (2012).","journal-title":"Hepatology"},{"key":"BFng3836_CR2","doi-asserted-by":"crossref","first-page":"6422","DOI":"10.1038\/ncomms7422","volume":"6","author":"M Eslam","year":"2015","unstructured":"Eslam, M. et al. Interferon-\u03bb rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease. Nat. Commun. 6, 6422 (2015).","journal-title":"Nat. Commun."},{"key":"BFng3836_CR3","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jhep.2015.11.008","volume":"64","author":"M Eslam","year":"2016","unstructured":"Eslam, M. et al. FibroGENE: a gene-based model for staging liver fibrosis. J. Hepatol. 64, 390\u2013398 (2016).","journal-title":"J. Hepatol."},{"key":"BFng3836_CR4","first-page":"1220a","volume":"52","author":"AJ Thompson","year":"2010","unstructured":"Thompson, A.J. et al. Genome wide-association study identifies Il28b polymorphism to be associated with baseline alt and hepatic necro-inflammatory activity in chronic hepatitis C patients enrolled in the Ideal Study. Hepatology 52, 1220a\u20131221a (2010).","journal-title":"Hepatology"},{"key":"BFng3836_CR5","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ng.2521","volume":"45","author":"L Prokunina-Olsson","year":"2013","unstructured":"Prokunina-Olsson, L. et al. A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat. Genet. 45, 164\u2013171 (2013).","journal-title":"Nat. Genet."},{"key":"BFng3836_CR6","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/ni.2758","volume":"15","author":"AP McFarland","year":"2014","unstructured":"McFarland, A.P. et al. The favorable IFNL3 genotype escapes mRNA decay mediated by AU-rich elements and hepatitis C virus\u2013induced microRNAs. Nat. Immunol. 15, 72\u201379 (2014).","journal-title":"Nat. Immunol."},{"key":"BFng3836_CR7","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI30542","volume":"117","author":"JP Iredale","year":"2007","unstructured":"Iredale, J.P. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J. Clin. Invest. 117, 539\u2013548 (2007).","journal-title":"J. Clin. Invest."},{"key":"BFng3836_CR8","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/ni.3212","volume":"16","author":"A Wack","year":"2015","unstructured":"Wack, A., Terczyn\u0144ska-Dyla, E. & Hartmann, R. Guarding the frontiers: the biology of type III interferons. Nat. Immunol. 16, 802\u2013809 (2015).","journal-title":"Nat. Immunol."},{"key":"BFng3836_CR9","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1126\/science.1258025","volume":"347","author":"MT Baldridge","year":"2015","unstructured":"Baldridge, M.T. et al. Commensal microbes and interferon-\u03bb determine persistence of enteric murine norovirus infection. Science 347, 266\u2013269 (2015).","journal-title":"Science"},{"key":"BFng3836_CR10","doi-asserted-by":"crossref","first-page":"5670","DOI":"10.1128\/JVI.00272-10","volume":"84","author":"M Mordstein","year":"2010","unstructured":"Mordstein, M. et al. \u03bb interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J. Virol. 84, 5670\u20135677 (2010).","journal-title":"J. Virol."},{"key":"BFng3836_CR11","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1053\/j.gastro.2011.12.055","volume":"142","author":"E Thomas","year":"2012","unstructured":"Thomas, E. et al. HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons. Gastroenterology 142, 978\u2013988 (2012).","journal-title":"Gastroenterology"},{"key":"BFng3836_CR12","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1002\/hep.25897","volume":"56","author":"H Park","year":"2012","unstructured":"Park, H. et al. IL-29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection. Hepatology 56, 2060\u20132070 (2012).","journal-title":"Hepatology"},{"key":"BFng3836_CR13","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","volume":"461","author":"D Ge","year":"2009","unstructured":"Ge, D. et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461, 399\u2013401 (2009).","journal-title":"Nature"},{"key":"BFng3836_CR14","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/ng.447","volume":"41","author":"V Suppiah","year":"2009","unstructured":"Suppiah, V. et al. IL28B is associated with response to chronic hepatitis C interferon-\u03b1 and ribavirin therapy. Nat. Genet. 41, 1100\u20131104 (2009).","journal-title":"Nat. Genet."},{"key":"BFng3836_CR15","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ng.449","volume":"41","author":"Y Tanaka","year":"2009","unstructured":"Tanaka, Y. et al. Genome-wide association of IL28B with response to pegylated interferon-\u03b1 and ribavirin therapy for chronic hepatitis C. Nat. Genet. 41, 1105\u20131109 (2009).","journal-title":"Nat. Genet."},{"key":"BFng3836_CR16","doi-asserted-by":"crossref","unstructured":"Rauch, A. et al. Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology 138, 1338\u20131345 (2010).","DOI":"10.1053\/j.gastro.2009.12.056"},{"key":"BFng3836_CR17","doi-asserted-by":"crossref","first-page":"e44915","DOI":"10.1371\/journal.pone.0044915","volume":"7","author":"A Dolganiuc","year":"2012","unstructured":"Dolganiuc, A. et al. Type III interferons, IL-28 and IL-29, are increased in chronic HCV infection and induce myeloid dendritic cell\u2013mediated FoxP3+ regulatory T cells. PLoS One 7, e44915 (2012).","journal-title":"PLoS One"},{"key":"BFng3836_CR18","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1007\/s00535-014-1023-2","volume":"50","author":"Y Aoki","year":"2015","unstructured":"Aoki, Y. et al. Association of serum IFN-\u03bb3 with inflammatory and fibrosis markers in patients with chronic hepatitis C virus infection. J. Gastroenterol. 50, 894\u2013902 (2015).","journal-title":"J. Gastroenterol."},{"key":"BFng3836_CR19","doi-asserted-by":"crossref","first-page":"e0141655","DOI":"10.1371\/journal.pone.0141655","volume":"10","author":"F Aboulnasr","year":"2015","unstructured":"Aboulnasr, F. et al. IFN-\u03bb inhibits miR-122 transcription through a Stat3\u2013HNF4\u03b1 inflammatory feedback loop in an IFN-\u03b1 resistant HCV cell culture system. PLoS One 10, e0141655 (2015).","journal-title":"PLoS One"},{"key":"BFng3836_CR20","doi-asserted-by":"crossref","first-page":"e108616","DOI":"10.1371\/journal.pone.0108616","volume":"9","author":"PK Chandra","year":"2014","unstructured":"Chandra, P.K. et al. Impaired expression of type I and type II interferon receptors in HCV-associated chronic liver disease and liver cirrhosis. PLoS One 9, e108616 (2014).","journal-title":"PLoS One"},{"key":"BFng3836_CR21","doi-asserted-by":"crossref","first-page":"e0121734","DOI":"10.1371\/journal.pone.0121734","volume":"10","author":"J Friborg","year":"2015","unstructured":"Friborg, J. et al. Impairment of type I but not type III IFN signaling by hepatitis C virus infection influences antiviral responses in primary human hepatocytes. PLoS One 10, e0121734 (2015).","journal-title":"PLoS One"},{"key":"BFng3836_CR22","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/hep.26788","volume":"59","author":"M Honda","year":"2014","unstructured":"Honda, M. et al. Hepatic interferon-stimulated genes are differentially regulated in the liver of chronic hepatitis C patients with different interleukin-28B genotypes. Hepatology 59, 828\u2013838 (2014).","journal-title":"Hepatology"},{"key":"BFng3836_CR23","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jhep.2010.08.020","volume":"54","author":"B Langhans","year":"2011","unstructured":"Langhans, B. et al. Interferon-\u03bb serum levels in hepatitis C. J. Hepatol. 54, 859\u2013865 (2011).","journal-title":"J. Hepatol."},{"key":"BFng3836_CR24","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1053\/j.gastro.2010.11.039","volume":"140","author":"MT Dill","year":"2011","unstructured":"Dill, M.T. et al. Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C. Gastroenterology 140, 1021\u20131031 (2011).","journal-title":"Gastroenterology"},{"key":"BFng3836_CR25","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1002\/hep.26182","volume":"57","author":"S Yoshio","year":"2013","unstructured":"Yoshio, S. et al. Human blood dendritic cell antigen 3 (BDCA3)+ dendritic cells are a potent producer of interferon-\u03bb in response to hepatitis C virus. Hepatology 57, 1705\u20131715 (2013).","journal-title":"Hepatology"},{"key":"BFng3836_CR26","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s00535-013-0814-1","volume":"49","author":"K Murata","year":"2014","unstructured":"Murata, K. et al. Ex vivo induction of IFN-\u03bb3 by a TLR7 agonist determines response to Peg-IFN\/ribavirin therapy in chronic hepatitis C patients. J. Gastroenterol. 49, 126\u2013137 (2014).","journal-title":"J. Gastroenterol."},{"key":"BFng3836_CR27","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/gutjnl-2012-302553","volume":"62","author":"T Watanabe","year":"2013","unstructured":"Watanabe, T. et al. Hepatitis C virus kinetics by administration of pegylated interferon-\u03b1 in human and chimeric mice carrying human hepatocytes with variants of the IL28B gene. Gut 62, 1340\u20131346 (2013).","journal-title":"Gut"},{"key":"BFng3836_CR28","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1002\/hep.23912","volume":"52","author":"TJ Urban","year":"2010","unstructured":"Urban, T.J. et al. IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C. Hepatology 52, 1888\u20131896 (2010).","journal-title":"Hepatology"},{"key":"BFng3836_CR29","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1093\/jac\/dkr598","volume":"67","author":"NI Rall\u00f3n","year":"2012","unstructured":"Rall\u00f3n, N.I. et al. Impact of IL28B gene polymorphisms on interferon-\u03bb3 plasma levels during pegylated interferon-\u03b1\/ribavirin therapy for chronic hepatitis C in patients coinfected with HIV. J. Antimicrob. Chemother. 67, 1246\u20131249 (2012).","journal-title":"J. Antimicrob. Chemother."},{"key":"BFng3836_CR30","doi-asserted-by":"crossref","first-page":"e37054","DOI":"10.1371\/journal.pone.0037054","volume":"7","author":"X Shi","year":"2012","unstructured":"Shi, X. et al. IL28B genetic variation is associated with spontaneous clearance of hepatitis C virus, treatment response, serum IL-28B levels in Chinese population. PLoS One 7, e37054 (2012).","journal-title":"PLoS One"},{"key":"BFng3836_CR31","doi-asserted-by":"crossref","first-page":"16037","DOI":"10.1038\/srep16037","volume":"5","author":"YF Lu","year":"2015","unstructured":"Lu, Y.F. et al. IFNL3 mRNA structure is remodeled by a functional non-coding polymorphism associated with hepatitis C virus clearance. Sci. Rep. 5, 16037 (2015).","journal-title":"Sci. Rep."},{"key":"BFng3836_CR32","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1089\/jir.2014.0161","volume":"35","author":"OO Onabajo","year":"2015","unstructured":"Onabajo, O.O. et al. Expression of interferon \u03bb4 is associated with reduced proliferation and increased cell death in human hepatic cells. J. Interferon Cytokine Res. 35, 888\u2013900 (2015).","journal-title":"J. Interferon Cytokine Res."},{"key":"BFng3836_CR33","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.virol.2014.12.020","volume":"476","author":"YF Lu","year":"2015","unstructured":"Lu, Y.F., Goldstein, D.B., Urban, T.J. & Bradrick, S.S. Interferon-\u03bb4 is a cell-autonomous type III interferon associated with pre-treatment hepatitis C virus burden. Virology 476, 334\u2013340 (2015).","journal-title":"Virology"},{"key":"BFng3836_CR34","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1038\/emboj.2013.232","volume":"32","author":"OJ Hamming","year":"2013","unstructured":"Hamming, O.J. et al. Interferon \u03bb4 signals via the IFN\u03bb receptor to regulate antiviral activity against HCV and coronaviruses. EMBO J. 32, 3055\u20133065 (2013).","journal-title":"EMBO J."},{"key":"BFng3836_CR35","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.1038\/ncomms6699","volume":"5","author":"E Terczyn\u0144ska-Dyla","year":"2014","unstructured":"Terczyn\u0144ska-Dyla, E. et al. Reduced IFN\u03bb4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes. Nat. Commun. 5, 5699 (2014).","journal-title":"Nat. Commun."},{"key":"BFng3836_CR36","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jhep.2015.06.035","volume":"63","author":"TR O'Brien","year":"2015","unstructured":"O'Brien, T.R. et al. Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance. J. Hepatol. 63, 1103\u20131110 (2015).","journal-title":"J. Hepatol."},{"key":"BFng3836_CR37","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0168-8278(00)00097-0","volume":"34","author":"T Poynard","year":"2001","unstructured":"Poynard, T. et al. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C. J. Hepatol. 34, 730\u2013739 (2001).","journal-title":"J. Hepatol."},{"key":"BFng3836_CR38","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/gene.2015.23","volume":"16","author":"C Lauber","year":"2015","unstructured":"Lauber, C. et al. Transcriptome analysis reveals a classical interferon signature induced by IFN\u03bb4 in human primary cells. Genes Immun. 16, 414\u2013421 (2015).","journal-title":"Genes Immun."},{"key":"BFng3836_CR39","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nri3623","volume":"14","author":"A Pellicoro","year":"2014","unstructured":"Pellicoro, A., Ramachandran, P., Iredale, J.P. & Fallowfield, J.A. Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nat. Rev. Immunol. 14, 181\u2013194 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"BFng3836_CR40","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/hep.27129","volume":"60","author":"K Kazankov","year":"2014","unstructured":"Kazankov, K. et al. Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C. Hepatology 60, 521\u2013530 (2014).","journal-title":"Hepatology"},{"key":"BFng3836_CR41","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","volume":"24","author":"P Bedossa","year":"1996","unstructured":"Bedossa, P. & Poynard, T. An algorithm for the grading of activity in chronic hepatitis C. Hepatology 24, 289\u2013293 (1996).","journal-title":"Hepatology"},{"key":"BFng3836_CR42","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jhep.2014.03.039","volume":"61","author":"M Eslam","year":"2014","unstructured":"Eslam, M. et al. IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2\/3 infection. J. Hepatol. 61, 235\u2013241 (2014).","journal-title":"J. Hepatol."},{"key":"BFng3836_CR43","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","volume":"21","author":"JC Barrett","year":"2005","unstructured":"Barrett, J.C., Fry, B., Maller, J. & Daly, M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263\u2013265 (2005).","journal-title":"Bioinformatics"},{"key":"BFng3836_CR44","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/ng1706","volume":"38","author":"AD Skol","year":"2006","unstructured":"Skol, A.D., Scott, L.J., Abecasis, G.R. & Boehnke, M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat. Genet. 38, 209\u2013213 (2006).","journal-title":"Nat. Genet."}],"container-title":["Nature Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ng.3836.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng.3836","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/ng.3836","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/ng.3836.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T21:20:28Z","timestamp":1684444828000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ng.3836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,10]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["BFng3836"],"URL":"https:\/\/doi.org\/10.1038\/ng.3836","relation":{},"ISSN":["1061-4036","1546-1718"],"issn-type":[{"value":"1061-4036","type":"print"},{"value":"1546-1718","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,10]]},"assertion":[{"value":"3 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}